In prostate cancer as well as in TGFβ-induced EMT FGFR1-IIIc is upregulated as an independent mesenchymal marker and the reciprocally downregulated IIIb receptor is FGFR2 [50, 51]. The gene discussed is FGFR2; the disease is prostate carcinoma.